136 related articles for article (PubMed ID: 9827711)
1. The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma.
Aoyagi Y; Isokawa O; Suda T; Watanabe M; Suzuki Y; Asakura H
Cancer; 1998 Nov; 83(10):2076-82. PubMed ID: 9827711
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
Ueki T; Sakaguchi S; Miyajima Y; Hatono N; Tohara K; Nakabayashi S; Yao T; Kokawa H; Hirano M; Okumura M
Cancer; 2002 Aug; 95(3):596-604. PubMed ID: 12209753
[TBL] [Abstract][Full Text] [Related]
3. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
4. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
Huo TI; Huang YH; Lui WY; Wu JC; Lee PC; Chang FY; Lee SD
Oncol Rep; 2004 Feb; 11(2):543-50. PubMed ID: 14719097
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.
Toyoda H; Kumada T; Kaneoka Y; Osaki Y; Kimura T; Arimoto A; Oka H; Yamazaki O; Manabe T; Urano F; Chung H; Kudo M; Matsunaga T
J Hepatol; 2008 Aug; 49(2):223-32. PubMed ID: 18571271
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467
[TBL] [Abstract][Full Text] [Related]
7. Studies on the correlation among the fucosylation index, concentration of alpha-fetoprotein and des-gamma-carboxy prothrombin as prognostic indicators in hepatocellular carcinoma.
Igarashi H; Aoyagi Y; Suda T; Mita Y; Kawai K
Hepatol Res; 2003 Dec; 27(4):280-288. PubMed ID: 14662116
[TBL] [Abstract][Full Text] [Related]
8. The fucosylation index of serum alpha-fetoprotein as useful prognostic factor in patients with hepatocellular carcinoma in special reference to chronological changes.
Aoyagi Y; Mita Y; Suda T; Kawai K; Kuroiwa T; Igarashi M; Kobayashi M; Waguri N; Asakura H
Hepatol Res; 2002 Aug; 23(4):287. PubMed ID: 12191676
[TBL] [Abstract][Full Text] [Related]
9. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
Fujioka M; Nakashima Y; Nakashima O; Kojiro M
Hepatology; 2001 Dec; 34(6):1128-34. PubMed ID: 11732002
[TBL] [Abstract][Full Text] [Related]
10. Preoperative combined with postoperative chemoembolization can improve survival in patients with hepatocellular carcinoma: a single-center study.
Liu Y; Yang R
J Vasc Interv Radiol; 2009 Apr; 20(4):472-83. PubMed ID: 19250841
[TBL] [Abstract][Full Text] [Related]
11. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
Sterling RK; Jeffers L; Gordon F; Venook AP; Reddy KR; Satomura S; Kanke F; Schwartz ME; Sherman M
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):104-13. PubMed ID: 18849011
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
[TBL] [Abstract][Full Text] [Related]
13. A new prognostic staging system for hepatocellular carcinoma: value of the biomarker combined Japan integrated staging score.
Kitai S; Kudo M; Minami Y; Ueshima K; Chung H; Hagiwara S; Inoue T; Ishikawa E; Takahashi S; Asakuma Y; Haji S; Osaki Y; Oka H; Seki T; Kasugai H; Sasaki Y; Matsunaga T
Intervirology; 2008; 51 Suppl 1():86-94. PubMed ID: 18544953
[TBL] [Abstract][Full Text] [Related]
14. The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma.
Nagaoka S; Yatsuhashi H; Hamada H; Yano K; Matsumoto T; Daikoku M; Arisawa K; Ishibashi H; Koga M; Sata M; Yano M
Cancer; 2003 Dec; 98(12):2671-7. PubMed ID: 14669288
[TBL] [Abstract][Full Text] [Related]
15. Triple positive tumor markers for hepatocellular carcinoma are useful predictors of poor survival.
Kiriyama S; Uchiyama K; Ueno M; Ozawa S; Hayami S; Tani M; Yamaue H
Ann Surg; 2011 Dec; 254(6):984-91. PubMed ID: 21606837
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients.
Xu HX; Lu MD; Xie XY; Yin XY; Kuang M; Chen JW; Xu ZF; Liu GJ
Clin Radiol; 2005 Sep; 60(9):1018-25. PubMed ID: 16124984
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of abnormal prothrombin (DCP) in relation to postoperative survival and prognosis in patients with hepatocellular carcinoma.
Inoue S; Nakao A; Harada A; Nonami T; Takagi H
Am J Gastroenterol; 1994 Dec; 89(12):2222-6. PubMed ID: 7526679
[TBL] [Abstract][Full Text] [Related]
18. Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers.
Toyoda H; Kumada T; Osaki Y; Oka H; Urano F; Kudo M; Matsunaga T
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1528-36. PubMed ID: 17162244
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma.
Hayashi K; Kumada T; Nakano S; Takeda I; Sugiyama K; Kiriyama S; Sone Y; Miyata A; Shimizu H; Satomura S
Am J Gastroenterol; 1999 Oct; 94(10):3028-33. PubMed ID: 10520864
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3.
Okuda H; Saito A; Shiratori K; Yamamoto M; Takasaki K; Nakano M
J Gastroenterol Hepatol; 2005 May; 20(5):759-64. PubMed ID: 15853991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
